Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Chloropyridine >  4-(BROMOMETHYL)-2-CHLOROPYRIDINE

4-(BROMOMETHYL)-2-CHLOROPYRIDINE

Basic information Safety Supplier Related

4-(BROMOMETHYL)-2-CHLOROPYRIDINE Basic information

Product Name:
4-(BROMOMETHYL)-2-CHLOROPYRIDINE
Synonyms:
  • 4-(BROMOMETHYL)-2-CHLOROPYRIDINE
  • Pyridine, 4-(bromomethyl)-2-chloro-
  • 4-(BROMOMETHYL)-2-CHLOROPYRIDINE ISO 9001:2015 REACH
  • 2-chloro-4-(bromomethyl)pyridine
CAS:
83004-15-3
MF:
C6H5BrClN
MW:
206.47
Mol File:
83004-15-3.mol
More
Less

4-(BROMOMETHYL)-2-CHLOROPYRIDINE Chemical Properties

storage temp. 
Inert atmosphere,Store in freezer, under -20°C
More
Less

4-(BROMOMETHYL)-2-CHLOROPYRIDINE Usage And Synthesis

Synthesis

100704-10-7

83004-15-3

Step 4b: (2-chloropyridin-4-yl)methanol (1.1 g, 7.3 mmol) was dissolved in 20 mL of dichloromethane (DCM) and cooled to 0°C after displacing the air within the reaction system with argon. Phosphorus tribromide (PBr3, 0.76 mL, 8.1 mmol) was added slowly dropwise via syringe and the solution was observed to become turbid. The reaction mixture was stirred at room temperature for 3 hours. Upon completion of the reaction, the mixture was cooled to 0 °C again and the reaction was quenched with 5 mL of water. The pH was adjusted by adding 2 M potassium carbonate (K2CO3) solution to the reaction mixture. the aqueous and organic layers were separated, and the aqueous layer was extracted three times with ethyl acetate (EtOAc). The aqueous layer was extracted with ethyl acetate (EtOAc) three times. All organic layers were combined, dried with anhydrous sodium sulfate (Na2SO4), filtered and concentrated. The concentrate was purified by silica gel column chromatography (the silica gel column was pre-washed with an eluent containing 1% triethylamine (NEt3)) using a gradient elution from hexane to ethyl acetate (EtOAc) to afford the target product, 4-bromomethyl-2-chloropyridine, as pale pink crystals (700 mg, calculated as 50% yield based on the recovered starting material). The product was confirmed by NMR hydrogen spectroscopy (300 MHz, CDCl3): δ 8.37 (d, J=5.1 Hz, 1H), 7.35 (s, 1H), 7.27-7.20 (m, 1H), 4.35 (s, 2H).

References

[1] Patent: WO2011/147038, 2011, A1. Location in patent: Page/Page column 43-44
[2] Patent: WO2016/97345, 2016, A1. Location in patent: Page/Page column 16; 17
[3] Patent: EP1602647, 2005, A1. Location in patent: Page/Page column 54
[4] Patent: US2004/248884, 2004, A1. Location in patent: Page 120
[5] Patent: WO2011/25851, 2011, A1. Location in patent: Page/Page column 58

4-(BROMOMETHYL)-2-CHLOROPYRIDINESupplier

Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66113011 17798518460
Email
cfzhang@aikonchem.com
SynAsst Chemical.
Tel
021-60343070
Shanghai Macklin Biochemical Co.,Ltd.
Tel
15221275939
Email
shenlinxing@macklin.cn
ChengDu TongChuangYuan Pharmaceutical Co.Ltd
Tel
028-83379370 13880556291
Email
tcy@tcypharm.com
Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com